Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies. Neuro Oncol. 2016 10; 18(10):1357-66.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
B7-H1 Antigen
Biomarkers, Tumor
Brain Neoplasms
Child
Child, Preschool
Female
Glioma
High-Throughput Nucleotide Sequencing
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lymphocytes, Tumor-Infiltrating
Male
Middle Aged
Mutation
Programmed Cell Death 1 Receptor
Young Adult